Neuropharmacological Effects of Quercetin: A Literature-Based Review

Quercetin (QUR) is a natural bioactive flavonoid that has been lately very studied for its beneficial properties in many pathologies. Its neuroprotective effects have been demonstrated in many in vitro studies, as well as in vivo animal experiments and human trials. QUR protects the organism against neurotoxic chemicals and also can prevent the evolution and development of neuronal injury and neurodegeneration. The present work aimed to summarize the literature about the neuroprotective effect of QUR using known database sources. Besides, this review focuses on the assessment of the potential utilization of QUR as a complementary or alternative medicine for preventing and treating neurodegenerative diseases. An up-to-date search was conducted in PubMed, Science Direct and Google Scholar for published work dealing with the neuroprotective effects of QUR against neurotoxic chemicals or in neuronal injury, and in the treatment of neurodegenerative diseases. Findings suggest that QUR possess neuropharmacological protective effects in neurodegenerative brain disorders such as Alzheimer’s disease, Amyloid β peptide, Parkinson’s disease, Huntington's disease, multiple sclerosis, and amyotrophic lateral sclerosis. In summary, this review emphasizes the neuroprotective effects of QUR and its advantages in being used in complementary medicine for the prevention and treatment o of different neurodegenerative diseases.

[1]  M. Otsuki.  Aging and Cognitive Function , 2022, Higher Brain Function Research.

[2]  Marwa N. Atallah,et al.  Protective effects of Zingiber officinale extract on myocardium and placenta against labetalol-induced histopathological, immune-histochemical, and ultrastructural alterations in pregnant rats , 2021, The Journal of Basic and Applied Zoology.

[3]  Manoj Kumar,et al.  Flavonoids as potential anti-platelet aggregation agents: from biochemistry to health promoting abilities , 2021, Critical reviews in food science and nutrition.

[4]  B. Salehi,et al.  Cinnamomum Species: Bridging Phytochemistry Knowledge, Pharmacological Properties and Toxicological Safety for Health Benefits , 2021, Frontiers in Pharmacology.

[5]  C. Porro,et al.  The Potential Neuroprotective Role of Free and Encapsulated Quercetin Mediated by miRNA against Neurological Diseases , 2021, Nutrients.

[6]  A. Oliveira,et al.  Quercetin-biapigenin nanoparticles are effective to penetrate the blood–brain barrier , 2021, Drug Delivery and Translational Research.

[7]  D. Kovačević,et al.  Nanoencapsulation of Promising Bioactive Compounds to Improve Their Absorption, Stability, Functionality and the Appearance of the Final Food Products , 2021, Molecules.

[8]  D. Calina,et al.  Thinking Outside the Ischemia Box: Advancements in the Use of Multiple Sclerosis Drugs in Ischemic Stroke , 2021, Journal of clinical medicine.

[9]  D. Calina,et al.  A Novel Nutraceutical Formulation Can Improve Motor Activity and Decrease the Stress Level in a Murine Model of Middle-Age Animals , 2021, Journal of clinical medicine.

[10]  D. Calina,et al.  ADORA2A rs5760423 and CYP1A2 rs762551 Polymorphisms as Risk Factors for Parkinson’s Disease , 2021, Journal of clinical medicine.

[11]  Efthalia Angelopoulou,et al.  Enlightening the neuroprotective effect of quercetin in epilepsy: From mechanism to therapeutic opportunities , 2021, Epilepsy & Behavior.

[12]  B. Salehi,et al.  Pharmacological Properties of Chalcones: A Review of Preclinical Including Molecular Mechanisms and Clinical Evidence , 2021, Frontiers in Pharmacology.

[13]  P. Li,et al.  Quercetin: Its Main Pharmacological Activity and Potential Application in Clinical Medicine , 2020, Oxidative medicine and cellular longevity.

[14]  Ana Flavia Burlec.  ESSENTIAL OILS IN WELLNESS CENTERS: OVERVIEW ON EUROPEAN UNION LEGISLATION, POTENTIAL THERAPEUTIC EFFECTS AND TOXICITY , 2020, FARMACIA.

[15]  L. Alvarez-Arellano,et al.  Neuroprotective Effects of Quercetin in Pediatric Neurological Diseases , 2020, Molecules.

[16]  B. Salehi,et al.  Pharmacological Activities of Psoralidin: A Comprehensive Review of the Molecular Mechanisms of Action , 2020, Frontiers in Pharmacology.

[17]  B. Salehi,et al.  Ficus plants: State of the art from a phytochemical, pharmacological, and toxicological perspective , 2020, Phytotherapy research : PTR.

[18]  Soo‐Ki Kim,et al.  Allium Flavonols: Health Benefits, Molecular Targets, and Bioavailability , 2020, Antioxidants.

[19]  C. Tonelli,et al.  The Therapeutic Potential of Anthocyanins: Current Approaches Based on Their Molecular Mechanism of Action , 2020, Frontiers in Pharmacology.

[20]  D. Calina,et al.  The Treatment of Cognitive, Behavioural and Motor Impairments from Brain Injury and Neurodegenerative Diseases through Cannabinoid System Modulation—Evidence from In Vivo Studies , 2020, Journal of clinical medicine.

[21]  M. Sharifi-Rad,et al.  Lifestyle, Oxidative Stress, and Antioxidants: Back and Forth in the Pathophysiology of Chronic Diseases , 2020, Frontiers in Physiology.

[22]  Xinjun Yu,et al.  Effect of Quercetin on PC12 Alzheimer's Disease Cell Model Induced by Aβ25-35 and Its Mechanism Based on Sirtuin1/Nrf2/HO-1 Pathway , 2020, BioMed research international.

[23]  M. Sharifi-Rad,et al.  Impact of Natural Compounds on Neurodegenerative Disorders: From Preclinical to Pharmacotherapeutics , 2020, Journal of clinical medicine.

[24]  M. Sharifi-Rad,et al.  Diet, Lifestyle and Cardiovascular Diseases: Linking Pathophysiology to Cardioprotective Effects of Natural Bioactive Compounds , 2020, International journal of environmental research and public health.

[25]  S. Reis,et al.  Quercetin lipid nanoparticles functionalized with transferrin for Alzheimer's disease. , 2020, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[26]  M. Ikram,et al.  The Pharmacological Activity, Biochemical Properties, and Pharmacokinetics of the Major Natural Polyphenolic Flavonoid: Quercetin , 2020, Foods.

[27]  B. Salehi,et al.  Curcumin’s Nanomedicine Formulations for Therapeutic Application in Neurological Diseases , 2020, Journal of clinical medicine.

[28]  B. Salehi,et al.  Avocado–Soybean Unsaponifiables: A Panoply of Potentialities to Be Exploited , 2020, Biomolecules.

[29]  Y. Qiu,et al.  Quercetin and Isoquercitrin Inhibiting Hepatic Gluconeogenesis Through LKB1-AMPKα Pathway. , 2020, Acta endocrinologica.

[30]  H. Boyina,et al.  In Silico and In Vivo Studies on Quercetin as Potential Anti-Parkinson Agent. , 2020, Advances in experimental medicine and biology.

[31]  M. Aschner,et al.  Neuroprotective Effects of Quercetin in Alzheimer’s Disease , 2019, Biomolecules.

[32]  D. Calina,et al.  Oxidative Stress and Inflammation Interdependence in Multiple Sclerosis , 2019, Journal of clinical medicine.

[33]  D. Hanganu.  EVALUATION OF POLYPHENOLIC PROFILE AND ANTIOXIDANT ACTIVITY FOR SOME SALVIA SPECIES , 2019, FARMACIA.

[34]  M. Marra,et al.  Dietary Quercetin and Kaempferol: Bioavailability and Potential Cardiovascular-Related Bioactivity in Humans , 2019, Nutrients.

[35]  N. Omi,et al.  Effects of enzymatically modified isoquercitrin in supplementary protein powder on athlete body composition: a randomized, placebo-controlled, double-blind trial , 2019, Journal of the International Society of Sports Nutrition.

[36]  J. Sharifi‐Rad,et al.  A Mechanistic and Pathophysiological Approach for Stroke Associated with Drugs of Abuse , 2019, Journal of clinical medicine.

[37]  B. Salehi,et al.  Veronica Plants—Drifting from Farm to Traditional Healing, Food Application, and Phytopharmacology , 2019, Molecules.

[38]  Z. Selamoğlu,et al.  Cucurbits Plants: A Key Emphasis to Its Pharmacological Potential , 2019, Molecules.

[39]  S. A. A. Shah,et al.  Molecular mechanisms underlying protective role of quercetin in attenuating Alzheimer's disease. , 2019, Life sciences.

[40]  D. Calina,et al.  Molecular and cellular stratagem of brain metastases associated with melanoma. , 2019, Oncology letters.

[41]  B. Salehi,et al.  Epibatidine: A Promising Natural Alkaloid in Health , 2018, Biomolecules.

[42]  Andy Wai Kan Yeung,et al.  When Neuroscience Meets Pharmacology: A Neuropharmacology Literature Analysis , 2018, Front. Neurosci..

[43]  A. Riva,et al.  Improved Oral Absorption of Quercetin from Quercetin Phytosome®, a New Delivery System Based on Food Grade Lecithin , 2018, European Journal of Drug Metabolism and Pharmacokinetics.

[44]  Nagaraja Haleagrahara,et al.  Current Concepts of Neurodegenerative Mechanisms in Alzheimer's Disease , 2018, BioMed research international.

[45]  M. Puiu,et al.  MODERN TREATMENT APPROACHES IN PSYCHOSES . PHARMACOGENETIC , NEUROIMAGISTIC AND CLINICAL IMPLICATIONS , 2017 .

[46]  N. Braidy,et al.  Bioactive effects of quercetin in the central nervous system: Focusing on the mechanisms of actions. , 2016, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[47]  D. Barreca,et al.  Neuroprotective Effects of Quercetin: From Chemistry to Medicine. , 2016, CNS & neurological disorders drug targets.

[48]  Huaxi Xu,et al.  Quercetin stabilizes apolipoprotein E and reduces brain Aβ levels in amyloid model mice , 2016, Neuropharmacology.

[49]  R. Sharma,et al.  Quercetin attenuates neuronal death against aluminum-induced neurodegeneration in the rat hippocampus , 2016, Neuroscience.

[50]  Li Jiang,et al.  Cholinergic Signaling Controls Conditioned Fear Behaviors and Enhances Plasticity of Cortical-Amygdala Circuits , 2016, Neuron.

[51]  Marjan Nassiri-Asl,et al.  Comparison between the effects of quercetin on seizure threshold in acute and chronic seizure models , 2016, Toxicology and industrial health.

[52]  Nagaraja Haleagrahara,et al.  Protective effects of quercetin glycosides, rutin, and isoquercetrin against 6-hydroxydopamine (6-OHDA)-induced neurotoxicity in rat pheochromocytoma (PC-12) cells , 2016, International journal of immunopathology and pharmacology.

[53]  Jianghong Wu,et al.  Therapeutic effects of quercetin on early inflammation in hypertriglyceridemia-related acute pancreatitis and its mechanism. , 2016, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

[54]  M. Kamal,et al.  Inflammatory Process in Alzheimer's and Parkinson's Diseases: Central Role of Cytokines. , 2016, Current pharmaceutical design.

[55]  O. Firuzi,et al.  Modulation of neurotrophic signaling pathways by polyphenols , 2015, Drug design, development and therapy.

[56]  P. Elumalai,et al.  Role of Quercetin Benefits in Neurodegeneration. , 2016, Advances in neurobiology.

[57]  G. Robertson,et al.  Synergistic neuroprotection by epicatechin and quercetin: Activation of convergent mitochondrial signaling pathways , 2015, Neuroscience.

[58]  L. Račková,et al.  Modulation of BV-2 microglia functions by novel quercetin pivaloyl ester , 2015, Neurochemistry International.

[59]  Á. Simonyi,et al.  Quercetin Attenuates Inflammatory Responses in BV-2 Microglial Cells: Role of MAPKs on the Nrf2 Pathway and Induction of Heme Oxygenase-1 , 2015, PloS one.

[60]  H. Valizadeh,et al.  Solid Lipid Nanoparticles and Nanostructured Lipid Carriers: Structure, Preparation and Application. , 2015, Advanced pharmaceutical bulletin.

[61]  V. Steimbach,et al.  Antidepressant-like effect of quercetin in bulbectomized mice and involvement of the antioxidant defenses, and the glutamatergic and oxidonitrergic pathways , 2015, Pharmacology Biochemistry and Behavior.

[62]  T. Inuzuka,et al.  Quercetin reduces eIF2α phosphorylation by GADD34 induction , 2015, Neurobiology of Aging.

[63]  Zong-fang Li,et al.  Neuroprotective effects of quercetin in a mouse model of brain ischemic/reperfusion injury via anti-apoptotic mechanisms based on the Akt pathway. , 2015, Molecular medicine reports.

[64]  Seo Yun Jung,et al.  Synthesis of (2-amino)ethyl derivatives of quercetin 3-O-methyl ether and their antioxidant and neuroprotective effects. , 2015, Bioorganic & medicinal chemistry.

[65]  A. Teixeira,et al.  Insights into Neuroinflammation in Parkinson's Disease: From Biomarkers to Anti-Inflammatory Based Therapies , 2015, BioMed research international.

[66]  J. R. Ramírez-Pineda,et al.  The flavonoid quercetin ameliorates Alzheimer's disease pathology and protects cognitive and emotional function in aged triple transgenic Alzheimer's disease model mice , 2015, Neuropharmacology.

[67]  K. Kawabata,et al.  Quercetin and related polyphenols: new insights and implications for their bioactivity and bioavailability. , 2015, Food & function.

[68]  Young-Jin Kim,et al.  Anti-inflammatory effect of chrysin on RAW 264.7 mouse macrophages induced with polyinosinic-polycytidylic acid , 2015, Biotechnology and Bioprocess Engineering.

[69]  O. Garaschuk,et al.  Neuroinflammation in Alzheimer's disease , 2015, The Lancet Neurology.

[70]  R. Bruno,et al.  Endogenous and exogenous mediators of quercetin bioavailability. , 2015, The Journal of nutritional biochemistry.

[71]  Yong-hui Shi,et al.  Differential effects of quercetin on hippocampus-dependent learning and memory in mice fed with different diets related with oxidative stress , 2015, Physiology & Behavior.

[72]  Y. Shokoohinia,et al.  Quercetin-3-O-β-D-glucopyranoside, a dietary flavonoid, protects PC12 cells from H₂O₂-induced cytotoxicity through inhibition of reactive oxygen species. , 2015, Food chemistry.

[73]  H. Sepehri,et al.  Quercetin improved spatial memory dysfunctions in rat model of intracerebroventricular streptozotocin-induced sporadic Alzheimer’s disease - , 2015 .

[74]  S. Appel,et al.  Protective and Toxic Neuroinflammation in Amyotrophic Lateral Sclerosis , 2015, Neurotherapeutics.

[75]  G. Raszewski,et al.  Effect of quercetin and rutin in some acute seizure models in mice , 2014, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[76]  Yea-Ru Yang,et al.  Quercetin enhances exercise-mediated neuroprotective effects in brain ischemic rats. , 2014, Medicine and science in sports and exercise.

[77]  U. Wenzel,et al.  Amyloid-beta (Aβ₁₋₄₂)-induced paralysis in Caenorhabditis elegans is inhibited by the polyphenol quercetin through activation of protein degradation pathways. , 2014, Molecular nutrition & food research.

[78]  M. Aydın,et al.  Ameliorating effect of quercetin on acute pentylenetetrazole induced seizures in rats. , 2014, International journal of clinical and experimental medicine.

[79]  D. Jain,et al.  Combination of lycopene, quercetin and poloxamer 188 alleviates anxiety and depression in 3-nitropropionic acid-induced Huntington’s disease in rats , 2014, Journal of intercultural ethnopharmacology.

[80]  P. Sahu,et al.  NEUROPROTECTIVE EFFECT OF QUERCETIN IN NEUROTOXICITY INDUCED RATS: ROLE OF NEUROINFLAMMATION IN NEURODEGENERATION , 2014 .

[81]  I. Goudarzi,et al.  Chronic administration of quercetin prevent spatial learning and memory deficits provoked by chronic stress in rats , 2014, Behavioural Brain Research.

[82]  V. Dressler,et al.  Quercetin protects the impairment of memory and anxiogenic-like behavior in rats exposed to cadmium: Possible involvement of the acetylcholinesterase and Na+,K+-ATPase activities , 2014, Physiology & Behavior.

[83]  Claudia Pellacani,et al.  Paraoxonase-2 (PON2) in brain and its potential role in neuroprotection. , 2014, Neurotoxicology.

[84]  L. Qu,et al.  Quercetin alleviates high glucose-induced Schwann cell damage by autophagy , 2014, Neural regeneration research.

[85]  R. Cavalli,et al.  Loading into Nanoparticles Improves Quercetin's Efficacy in Preventing Neuroinflammation Induced by Oxysterols , 2014, PloS one.

[86]  Xiang-qian Liu,et al.  Chemical constituents and their acetyl cholinesterase inhibitory and antioxidant activities from leaves of Acanthopanax henryi: potential complementary source against Alzheimer’s disease , 2013, Archives of Pharmacal Research.

[87]  Peter Natesan Pushparaj,et al.  Recent Updates in the Treatment of Neurodegenerative Disorders Using Natural Compounds , 2014, Evidence-based complementary and alternative medicine : eCAM.

[88]  N. Moustaid‐Moussa,et al.  Application of nanotechnology in improving bioavailability and bioactivity of diet-derived phytochemicals. , 2014, The Journal of nutritional biochemistry.

[89]  M. Vizcaychipi,et al.  Neuroinflammation: The role and consequences , 2014, Neuroscience Research.

[90]  K. Mohanakumar,et al.  Quercetin Improves Behavioral Deficiencies, Restores Astrocytes and Microglia, and Reduces Serotonin Metabolism in 3‐Nitropropionic Acid‐Induced Rat Model of Huntington's Disease , 2014, CNS neuroscience & therapeutics.

[91]  Roland Martin,et al.  The good and the bad of neuroinflammation in multiple sclerosis. , 2014, Handbook of clinical neurology.

[92]  S. Parvez,et al.  Nephroprotective activities of quercetin with potential relevance to oxidative stress induced by valproic acid , 2014, Protoplasma.

[93]  Nagaraja Haleagrahara,et al.  Protective effects of flavonol isoquercitrin, against 6-hydroxy dopamine (6-OHDA) - induced toxicity in PC12 cells , 2014, BMC Research Notes.

[94]  D. Prasad,et al.  Quercetin reverses hypobaric hypoxia-induced hippocampal neurodegeneration and improves memory function in the rat. , 2013, High altitude medicine & biology.

[95]  S. Chakraborty,et al.  In silico QSAR analysis of quercetin reveals its potential as therapeutic drug for Alzheimer's disease. , 2013, Journal of young pharmacists : JYP.

[96]  Toshiro K. Ohsumi,et al.  The Microglial Sensome Revealed by Direct RNA Sequencing , 2013, Nature Neuroscience.

[97]  K. Chopra,et al.  Neuroprotective effect of sesamol and quercetin against QA induced neurotoxicity: An experimental paradigm of Huntington's disease , 2013, Journal of the Neurological Sciences.

[98]  Geum-soog Kim,et al.  Protective effects of onion-derived quercetin on glutamate-mediated hippocampal neuronal cell death , 2013, Pharmacognosy magazine.

[99]  Charles F. Bearden,et al.  A Nondegenerate Code of Deleterious Variants in Mendelian Loci Contributes to Complex Disease Risk , 2013, Cell.

[100]  A. Nazir,et al.  Sirtuin mediated neuroprotection and its association with autophagy and apoptosis: Studies employing transgenic C. elegans model , 2013, Molecular Neurodegeneration.

[101]  G. Sancesario,et al.  Amyloid β, Glutamate, Excitotoxicity in Alzheimer's Disease: Are We on the Right Track? , 2013, CNS neuroscience & therapeutics.

[102]  R. Nixon,et al.  The role of autophagy in neurodegenerative disease , 2013, Nature Medicine.

[103]  M. Haghighi,et al.  Effects of quercetin on oxidative stress and memory retrieval in kindled rats , 2013, Epilepsy & Behavior.

[104]  M. Delgado,et al.  Neuroprotective Properties of Standardized Extracts of Hypericum perforatum on Rotenone Model of Parkinson's Disease. , 2013, CNS & neurological disorders drug targets.

[105]  V. Cavallaro,et al.  Send Orders of Reprints at Reprints@benthamscience.net Natural Ache Inhibitors from Plants and Their Contribution to Alzheimer's Disease Therapy , 2022 .

[106]  V. Morsch,et al.  Neuroprotective effect of quercetin in ectoenzymes and acetylcholinesterase activities in cerebral cortex synaptosomes of cadmium-exposed rats , 2013, Molecular and Cellular Biochemistry.

[107]  R. Niranjan.  The Role of Inflammatory and Oxidative Stress Mechanisms in the Pathogenesis of Parkinson’s Disease: Focus on Astrocytes , 2013, Molecular Neurobiology.

[108]  S. Tadtong,et al.  Neurite Outgrowth and Neuroprotective Effects of Quercetin from Caesalpinia mimosoides Lamk. on Cultured P19-Derived Neurons , 2013, Evidence-based complementary and alternative medicine : eCAM.

[109]  L. Tsai,et al.  A Dietary Regimen of Caloric Restriction or Pharmacological Activation of SIRT1 to Delay the Onset of Neurodegeneration , 2013, The Journal of Neuroscience.

[110]  C. Parsons,et al.  Memantine and Cholinesterase Inhibitors: Complementary Mechanisms in the Treatment of Alzheimer’s Disease , 2013, Neurotoxicity Research.

[111]  V. Vasić,et al.  Send Orders of Reprints at Reprints@benthamscience.net Acetylcholinesterase Inhibitors: Pharmacology and Toxicology , 2022 .

[112]  S. Karuppagounder,et al.  Quercetin up-regulates mitochondrial complex-I activity to protect against programmed cell death in rotenone model of Parkinson’s disease in rats , 2013, Neuroscience.

[113]  Min Zhu,et al.  Oxidized quercetin inhibits α-synuclein fibrillization. , 2013, Biochimica et biophysica acta.

[114]  C. Serhan,et al.  A Novel Anti-Inflammatory and Pro-Resolving Role for Resolvin D1 in Acute Cigarette Smoke-Induced Lung Inflammation , 2013, PloS one.

[115]  R. Sandhir,et al.  Quercetin supplementation is effective in improving mitochondrial dysfunctions induced by 3-nitropropionic acid: implications in Huntington's disease. , 2013, Biochimica et biophysica acta.

[116]  Baldev Singh,et al.  A review on cholinesterase inhibitors for Alzheimer’s disease , 2013, Archives of pharmacal research.

[117]  J. Simon,et al.  Identification of brain‐targeted bioactive dietary quercetin‐3‐O‐glucuronide as a novel intervention for Alzheimer's disease , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[118]  Muralidhara,et al.  Enhanced neuroprotective effect of fish oil in combination with quercetin against 3‐nitropropionic acid induced oxidative stress in rat brain , 2013, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[119]  L. Ming,et al.  Metal binding of flavonoids and their distinct inhibition mechanisms toward the oxidation activity of Cu2+-β-amyloid: not just serving as suicide antioxidants! , 2013, Inorganic chemistry.

[120]  M. Zenobi‐Wong,et al.  The Flavonoid Isoquercitrin Promotes Neurite Elongation by Reducing RhoA Activity , 2012, PloS one.

[121]  Pravir Kumar,et al.  Naringenin and quercetin reverse the effect of hypobaric hypoxia and elicit neuroprotective response in the murine model , 2012, Brain Research.

[122]  B. Hyman,et al.  The synaptic accumulation of hyperphosphorylated tau oligomers in Alzheimer disease is associated with dysfunction of the ubiquitin-proteasome system. , 2012, The American journal of pathology.

[123]  R. Kandimalla,et al.  Quercetin Protects Against Chronic Aluminum-Induced Oxidative Stress and Ensuing Biochemical, Cholinergic, and Neurobehavioral Impairments in Rats , 2012, Neurotoxicity Research.

[124]  Xiaochuan Wang,et al.  Antioxidant Therapies for Alzheimer's Disease , 2012, Oxidative medicine and cellular longevity.

[125]  Seo Yun Jung,et al.  Neuroprotective Effects of Quercetin 3-O-Methyl Ether, Quercetin and (±)-Dihydroquercetin in a Rat Model of Transient Focal Cerebral Ischemia , 2012 .

[126]  M. Martinoli,et al.  Quercetin and Sesamin Protect Dopaminergic Cells from MPP+-Induced Neuroinflammation in a Microglial (N9)-Neuronal (PC12) Coculture System , 2012, Oxidative medicine and cellular longevity.

[127]  S. Gandhi,et al.  Mechanism of Oxidative Stress in Neurodegeneration , 2012, Oxidative medicine and cellular longevity.

[128]  J. Kim,et al.  Effect of quercetin on learning and memory performance in ICR mice under neurotoxic trimethyltin exposure , 2012 .

[129]  T. Hong,et al.  Effect of Quercetin in the 1-Methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-Induced Mouse Model of Parkinson's Disease , 2012, Evidence-based complementary and alternative medicine : eCAM.

[130]  Joshua A. Smith,et al.  Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases , 2012, Brain Research Bulletin.

[131]  S. Tiamkao,et al.  Cognitive-Enhancing Effect of Quercetin in a Rat Model of Parkinson's Disease Induced by 6-Hydroxydopamine , 2011, Evidence-based complementary and alternative medicine : eCAM.

[132]  S. Martín-Aragón,et al.  Quercetin and rutin exhibit antiamyloidogenic and fibril-disaggregating effects in vitro and potent antioxidant activity in APPswe cells. , 2011, Life sciences.

[133]  K. Fujimori,et al.  Protective effects of quercetin against hydrogen peroxide-induced apoptosis in human neuronal SH-SY5Y cells , 2011, Neuroscience Letters.

[134]  Y. Marunaka,et al.  Quercetin Stimulates NGF-induced Neurite Outgrowth in PC12 Cells via Activation of Na+/K+/2Cl- Cotransporter , 2011, Cellular Physiology and Biochemistry.

[135]  A. N. Kalia,et al.  Antiepileptic potential of flavonoids fraction from the leaves of Anisomeles malabarica. , 2011, Journal of ethnopharmacology.

[136]  M. Schuler,et al.  Citrus flavonoids luteolin, apigenin, and quercetin inhibit glycogen synthase kinase-3β enzymatic activity by lowering the interaction energy within the binding cavity. , 2011, Journal of medicinal food.

[137]  M. Bogo,et al.  Quercetin and rutin prevent scopolamine-induced memory impairment in zebrafish , 2011, Behavioural Brain Research.

[138]  E. Waxman,et al.  Characterization of kinases involved in the phosphorylation of aggregated α‐synuclein , 2011, Journal of neuroscience research.

[139]  P. Okunieff,et al.  Antioxidant properties of quercetin. , 2011, Advances in experimental medicine and biology.

[140]  A. Nieoullon.  Neurodegenerative diseases and neuroprotection: current views and prospects , 2011 .

[141]  Dong-Mei Wu,et al.  Quercetin activates AMP‐activated protein kinase by reducing PP2C expression protecting old mouse brain against high cholesterol‐induced neurotoxicity , 2010, The Journal of pathology.

[142]  N. Chondrogianni,et al.  Anti-ageing and rejuvenating effects of quercetin , 2010, Experimental Gerontology.

[143]  Dean P. Jones,et al.  After cellular internalization, quercetin causes Nrf2 nuclear translocation, increases glutathione levels, and prevents neuronal death against an oxidative insult. , 2010, Free radical biology & medicine.

[144]  K. Manaye,et al.  Anti-depressant natural flavonols modulate BDNF and beta amyloid in neurons and hippocampus of double TgAD mice , 2010, Neuropharmacology.

[145]  L. Goya,et al.  Quercetin Modulates NF-κ B and AP-1/JNK Pathways to Induce Cell Death in Human Hepatoma Cells , 2010, Nutrition and cancer.

[146]  Fred H. Gage,et al.  Mechanisms Underlying Inflammation in Neurodegeneration , 2010, Cell.

[147]  Jeonghoon Heo,et al.  Quercetin enhances TRAIL-induced apoptosis in prostate cancer cells via increased protein stability of death receptor 5. , 2010, Life sciences.

[148]  M. Tymianski,et al.  Calcium, ischemia and excitotoxicity. , 2010, Cell calcium.

[149]  E. Schültke,et al.  Quercetin in an animal model of spinal cord compression injury: correlation of treatment duration with recovery of motor function , 2010, Spinal Cord.

[150]  J. Midiwo,et al.  Pretreatment with natural flavones and neuronal cell survival after oxidative stress: a structure-activity relationship study. , 2010, Journal of agricultural and food chemistry.

[151]  Zhuo Yang,et al.  Quercetin improves cognitive deficits in rats with chronic cerebral ischemia and inhibits voltage‐dependent sodium channels in hippocampal CA1 pyramidal neurons , 2010, Phytotherapy research : PTR.

[152]  Jie Xu,et al.  Protective effects of Ginkgo biloba extract (EGb761) and its constituents quercetin and ginkgolide B against beta-amyloid peptide-induced toxicity in SH-SY5Y cells. , 2009, Chemico-biological interactions.

[153]  G. Rimbach,et al.  Effect of Quercetin on Paraoxonase 2 Levels in RAW264.7 Macrophages and in Human Monocytes––Role of Quercetin Metabolism , 2009, International journal of molecular sciences.

[154]  M. Nair,et al.  The Flavonoid, Quercetin, Inhibits HIV-1 Infection in Normal Peripheral Blood Mononuclear Cells , 2009 .

[155]  T. Höfer,et al.  Multisite protein phosphorylation – from molecular mechanisms to kinetic models , 2009, The FEBS journal.

[156]  Z. Qin,et al.  Molecular mechanisms of excitotoxicity and their relevance to pathogenesis of neurodegenerative diseases , 2009, Acta Pharmacologica Sinica.

[157]  D. Butterfield,et al.  Protective effect of quercetin in primary neurons against Abeta(1-42): relevance to Alzheimer's disease. , 2009, The Journal of nutritional biochemistry.

[158]  Paolo Zamboni,et al.  Oxidative Stress and Neurodegenerative Diseases: A Review of Upstream and Downstream Antioxidant Therapeutic Options , 2009, Current neuropharmacology.

[159]  M. Joghataei,et al.  Neuroprotective effect of quercetin in a model of Parkinson’s disease in rat: A histochemical analysis , 2009 .

[160]  A. Dias,et al.  Quercetin, kaempferol and biapigenin fromhypericum perforatum are neuroprotective against excitotoxic insults , 2008, Neurotoxicity Research.

[161]  W. Klein,et al.  Stimulation of neurogenesis and synaptogenesis by bilobalide and quercetin via common final pathway in hippocampal neurons. , 2009, Journal of Alzheimer's disease : JAD.

[162]  F. Munschauer,et al.  Quercetin and interferon-β modulate immune response(s) in peripheral blood mononuclear cells isolated from multiple sclerosis patients , 2008, Journal of Neuroimmunology.

[163]  Anil Kumar,et al.  Protective effect of quercetin against ICV colchicine‐induced cognitive dysfunctions and oxidative damage in rats , 2008, Phytotherapy research : PTR.

[164]  N. Saul,et al.  Quercetin-mediated longevity in Caenorhabditis elegans: Is DAF-16 involved? , 2008, Mechanisms of Ageing and Development.

[165]  Fei Liu,et al.  Microtubule-associated protein tau in development, degeneration and protection of neurons , 2008, Progress in Neurobiology.

[166]  E. Waxman,et al.  Specificity and Regulation of Casein Kinase-Mediated Phosphorylation of &agr;-Synuclein , 2008, Journal of neuropathology and experimental neurology.

[167]  T. Kihara,et al.  Flavonols and flavones as BACE-1 inhibitors: structure-activity relationship in cell-free, cell-based and in silico studies reveal novel pharmacophore features. , 2008, Biochimica et biophysica acta.

[168]  A. Raasmaja,et al.  Lack of robust protective effect of quercetin in two types of 6-hydroxydopamine-induced parkinsonian models in rats and dopaminergic cell cultures , 2008, Brain Research.

[169]  J. Cummings,et al.  Disease-modifying therapies in Alzheimer’s disease ⁎ ⁎ EDITOR’S NOTE: The Journal intended to include this article in the January 2008 supplement, “Leon Thal Symposium on Prevention of Dementia.” , 2008, Alzheimer's & Dementia.

[170]  Seung-Up Kim,et al.  Anti-inflammatory mechanism of intravascular neural stem cell transplantation in haemorrhagic stroke. , 2008, Brain : a journal of neurology.

[171]  M. Martinoli,et al.  Resveratrol and quercetin, two natural polyphenols, reduce apoptotic neuronal cell death induced by neuroinflammation , 2008, Journal of neuroscience research.

[172]  Osama Sabri,et al.  Acetylcholine receptors in dementia and mild cognitive impairment , 2008, European Journal of Nuclear Medicine and Molecular Imaging.

[173]  Mankil Jung,et al.  Acetylcholinesterase inhibition by flavonoids from Agrimonia pilosa. , 2007, Molecules.

[174]  A. Basu,et al.  Modulation of interleukin-1β mediated inflammatory response in human astrocytes by flavonoids: Implications in neuroprotection , 2007, Brain Research Bulletin.

[175]  L. Luo,et al.  Quercetin attenuates spontaneous behavior and spatial memory impairment in d-galactose–treated mice by increasing brain antioxidant capacity , 2007 .

[176]  X. Ning,et al.  Effect of quercetin on chronic enhancement of spatial learning and memory of mice , 2006, Science in China Series C: Life Sciences.

[177]  Anders Wallin,et al.  An Alzheimer's disease-specific β-amyloid fragment signature in cerebrospinal fluid , 2006, Neuroscience Letters.

[178]  Dong-Mei Wu,et al.  Quercetin reverses d-galactose induced neurotoxicity in mouse brain , 2006, Behavioural Brain Research.

[179]  I. Arts,et al.  SIRT1 stimulation by polyphenols is affected by their stability and metabolism , 2006, Mechanisms of Ageing and Development.

[180]  Yen-Chou Chen,et al.  Quercetin inhibition of ROS-dependent and -independent apoptosis in rat glioma C6 cells. , 2006, Toxicology.

[181]  C. Cetrulo,et al.  Regulation of IL‐1‐induced selective IL‐6 release from human mast cells and inhibition by quercetin , 2006, British journal of pharmacology.

[182]  M. Shoichet,et al.  Immobilized concentration gradients of neurotrophic factors guide neurite outgrowth of primary neurons in macroporous scaffolds. , 2006, Tissue engineering.

[183]  Byeoung-Soo Park,et al.  Effects of naturally occurring compounds on fibril formation and oxidative stress of beta-amyloid. , 2005, Journal of agricultural and food chemistry.

[184]  Wan-Wan Lin,et al.  Inhibition of iNOS gene expression by quercetin is mediated by the inhibition of IkappaB kinase, nuclear factor-kappa B and STAT1, and depends on heme oxygenase-1 induction in mouse BV-2 microglia. , 2005, European journal of pharmacology.

[185]  Dongzhi Wei,et al.  Protective effects of hyperoside (quercetin-3-o-galactoside) to PC12 cells against cytotoxicity induced by hydrogen peroxide and tert-butyl hydroperoxide. , 2005, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[186]  Rebecca P Seal,et al.  Molecular pharmacology of glutamate transporters, EAATs and VGLUTs , 2004, Brain Research Reviews.

[187]  A. S. Hamzah,et al.  Evaluation of antioxidant and nitric oxide inhibitory activities of selected Malaysian medicinal plants. , 2004, Journal of ethnopharmacology.

[188]  D. Begley,et al.  Flavonoid permeability across an in situ model of the blood-brain barrier. , 2004, Free radical biology & medicine.

[189]  C. Oliveira,et al.  Mitochondrial Dysfunction and Reactive Oxygen Species in Excitotoxicity and Apoptosis: Implications for the Pathogenesis of Neurodegenerative Diseases , 2003, Neurochemical Research.

[190]  A. Takashima,et al.  Potent anti‐amyloidogenic and fibril‐destabilizing effects of polyphenols in vitro: implications for the prevention and therapeutics of Alzheimer's disease , 2003, Journal of neurochemistry.

[191]  Y. Song,et al.  Neuroprotective effects of antioxidative flavonoids, quercetin, (+)-dihydroquercetin and quercetin 3-methyl ether, isolated from Opuntia ficus-indica var. saboten , 2003, Brain Research.

[192]  T. K. van den Berg,et al.  Flavonoids inhibit myelin phagocytosis by macrophages; a structure-activity relationship study. , 2003, Biochemical pharmacology.

[193]  S. Kulkarni,et al.  Reversal of Aging and Chronic Ethanol-induced Cognitive Dysfunction by Quercetin a Bioflavonoid , 2003, Free radical research.

[194]  Yuan Luo,et al.  Elevation of oxidative free radicals in Alzheimer's disease models can be attenuated by Ginkgo biloba extract EGb 761. , 2003, Journal of Alzheimer's disease : JAD.

[195]  Debomoy K Lahiri,et al.  Butyrylcholinesterase: An Important New Target in Alzheimer's Disease Therapy , 2002, International Psychogeriatrics.

[196]  E. Melamed,et al.  Oxidative stress induced-neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier , 2001, Neuropharmacology.

[197]  Y. Sagara,et al.  Flavonoids protect neuronal cells from oxidative stress by three distinct mechanisms. , 2001, Free radical biology & medicine.

[198]  F. Marshall,et al.  Heterodimerization of G-protein-coupled receptors in the CNS. , 2001, Current opinion in pharmacology.

[199]  D. Selkoe.  Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid beta-protein. , 2001, Journal of Alzheimer's disease : JAD.

[200]  N. Inestrosa,et al.  Acetylcholinesterase–amyloid‐β‐peptide interaction and Wnt signaling involvement in Aβ neurotoxicity , 2000 .

[201]  S. Wolffram,et al.  Bioavailability and metabolism of the flavonol quercetin in the pig. , 2000, Free radical biology & medicine.

[202]  D. Graham,et al.  Tissue tears in the white matter after lateral fluid percussion brain injury in the rat: relevance to human brain injury , 2000, Acta Neuropathologica.

[203]  J Q Trojanowski,et al.  Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. , 1998, The American journal of pathology.

[204]  C. Fischer,et al.  Induction of Zygotic Polyembryos in Wheat: Influence of Auxin Polar Transport. , 1997, The Plant cell.

[205]  D. Choi.  Excitotoxic cell death. , 1992, Journal of neurobiology.

[206]  Christine K. Carrico,et al.  Frontiers in pharmacology , 1983 .